- Your body already makes GHK-Cu, and the amount circulating falls by roughly 60% between your twenties and your sixties. That decline runs alongside visible ageing.
- It works four ways: it shifts the activity of thousands of genes, prompts collagen, calms inflammation, and gets your cells making their own antioxidants.
- Topical GHK-Cu in skin products has the most human evidence, and reported reactions are mild. Nobody has tested it head to head against retinol, so any ranking of the two is opinion.
- Injectable GHK-Cu is not approved by the FDA for any use and has almost no clinical data behind it.
- Genes linked to collagen, antioxidant defence and scarring vary between people, but no study has tested whether any genotype changes response to GHK-Cu.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring three-amino-acid peptide that your body already produces. The amount circulating in blood falls by roughly 60% between your twenties and age sixty.
Drop in natural GHK-Cu between age 20 and 60. That decline runs alongside visible ageing, slower wound healing, and less tissue repair.
Interest in GHK-Cu has climbed fast, and most content stops at "it's good for skin." This page separates what has been shown in people from what has been shown in a dish or in preclinical work. It is a summary of research, not a recommendation.
GHK-Cu is a small signalling molecule your body makes, and levels in the blood fall with age. Whether adding more from outside reverses anything is a separate question, and for most uses the human evidence is thin.
What does GHK-Cu actually do in your body?
GHK-Cu isn't a single-trick peptide. It operates through four distinct biological pathways, which is why it turns up in research spanning everything from wound healing to nerve disease.
Imagine your genome has thousands of switches. Over time, some that should be "on" flip off, and vice versa. In laboratory work, GHK-Cu pushes some of those switches back toward their younger positions. It doesn't change your DNA. It changes which parts are active.
What does the evidence show, use by use?
Not all use cases have the same evidence level. Here's an honest breakdown by how strong the science actually is:
Skin Anti-Aging
Human work on topical products reports firmer, more elastic skin and reduced sun damage. What none of it includes is a number you can hold anyone to: no published trial reports a percentage gain in skin density, and no trial has compared GHK-Cu against retinol in the same participants. Anyone quoting either is quoting nothing.
Caveat: These results are from topical application. Injectable GHK-Cu for skin ageing has almost no clinical data behind it.
Wound Healing
Speeds wound closure across several preclinical models. It draws in immune cells, encourages new blood vessels to grow into the wound, and lays down collagen. Studies of surgical wounds report faster closure and less scarring with GHK-Cu dressings.
Hair Growth
In laboratory work, it lengthened the active growing phase of hair follicles and enlarged the follicle itself. No controlled human trial has shown that it regrows hair.
Joint & Connective Tissue
In laboratory work, it prompted production of the molecules cartilage is built from. There is no human joint trial.
Does GHK-Cu do anything for hair?
This is one of the most common reasons people look it up, and it is the claimed benefit with the widest gap between how confidently it is sold and what has actually been shown.
The mechanistic argument is reasonable. Hair follicles sit in the dermis, they depend on the surrounding connective tissue and blood supply, and GHK-Cu acts on both. Copper peptides also appear to influence the enzyme pathway that converts testosterone to DHT, which is the hormone implicated in pattern hair loss. On paper it fits.
What is missing is the human trial. There is no controlled study in people showing GHK-Cu regrows hair, in the way there is for minoxidil or finasteride. What exists is laboratory work on follicle cells, preclinical data and a large amount of anecdote.
For hair loss, GHK-Cu is not in the same evidence category as the approved options, minoxidil and finasteride. Hair loss is worth taking to a dermatologist.
Why it turns up in hair products anyway
Copper peptides are a common ingredient in scalp serums, usually alongside other actives such as caffeine, ketoconazole or minoxidil. When people report results from those products, attributing the result to the copper peptide specifically is a guess, since the formulation rarely contains only one active.
What has actually been tested in people
Most of what gets quoted about GHK-Cu comes from laboratory and preclinical work. That is not a dismissal, it is where the mechanism was worked out, but it is worth separating from the studies done in humans.
The full citation list, tagged by whether each study was in humans, preclinical or in a dish, is on the GHK-Cu reference page.
Where genetics fits
Several genes sit on the pathways GHK-Cu acts on in laboratory studies, and their common variants have been studied for links to skin, collagen and healing traits.
No study has tested whether any of these genotypes changes response to GHK-Cu. A DNA report can show which versions you carry and what the research on them does show; it cannot predict what GHK-Cu would do for you.
How does GHK-Cu compare with retinol?
The most common comparison in skincare, and the honest answer is that nobody knows which does more. No trial has put the two in the same study, on the same faces, measured the same way. What can be said is that they work by different routes and have very different amounts of evidence behind them.
| GHK-Cu | Retinol | |
|---|---|---|
| Mechanism | Shifts gene activity, carries copper into enzymes | Binds retinoic acid receptors |
| Time to results in studies | Months, not weeks; no trial has timed it precisely | Months, with the first changes usually reported around 12 weeks |
| Irritation reported | Mild: redness, itching or stinging where applied | Dryness, peeling, sun sensitivity |
| Evidence base | Smaller; mostly laboratory, with some human skin studies | Large; many clinical trials |
Retinol has decades of clinical trials behind it and is known to irritate. GHK-Cu works on skin by a different route and has a smaller evidence base. Which of them does more for skin is untested.
Topical and injectable forms are different questions
Almost all of the human evidence on GHK-Cu concerns topical products, creams and serums applied to skin, which are sold as cosmetics. Injectable GHK-Cu is a different matter: it is not approved by the FDA for any use, and it has almost no clinical data behind it. The evidence for one does not carry over to the other.
What studies and users have reported
For topical products, the reported reactions are ordinary: redness, itching, stinging or dryness where the product is applied, usually settling over time. Copper can also temporarily tint the skin a faint blue-green, which washes off and is cosmetic rather than a warning sign.
The "copper uglies"
Worth naming because people search for it and then panic. Some users report that skin looks briefly worse after they begin using copper peptide products: more texture, more visible fine lines, a slack quality for a few weeks. The proposed explanation is that GHK-Cu influences the enzymes that break down old collagen as well as those that build new, so there may be a window where the old matrix is being cleared faster than the new one is laid down.
This is a reported pattern with a plausible mechanism rather than something a trial has demonstrated. No study has shown that a period of worsening is a harmless or expected stage.
Copper exposure differs by route
Topical copper peptide products are not a realistic route to copper overload; the amounts are small and skin absorption is limited, which our reference page covers with the penetration data. Injectable copper is a different matter, with no long-term human safety data.
Where the research has gaps, or where a doctor is the right person to ask
Results, and how long studies take to see them
Skin turnover takes weeks and collagen takes longer, so this is a compound measured in months rather than days. We put the week-by-week picture, including what the published timelines actually show, in GHK-Cu before and after.
The rest of the category
The copper peptide and its neighbours
Studied for skin rather than for injuries.
Everything else we have on GHK-Cu
This page is the overview. If you want a specific part of it in depth:
- The reference page for the full study list and marker data.
- How it works for the mechanism in detail.
- Before and after for the week-by-week timeline and what the trials measured.
- Versus retinol and vitamin C for how it compares on evidence.
- Why reported skin results vary, and what genetics can and cannot say.
- What research has examined across the wider skin category.
Watch
What clinicians and researchers say about GHK-Cu
1 hr 30 minPeptide Expert: What Do Peptides Actually Do? (EXPLAINED) - Dr Alex TatemThe Diary of a CEO · PodcastBPC-157TB-500MOTS-c
2 hr 48 minPeptides: The Science, Uses & Safety | Dr. Abud BakriAndrew Huberman · ResearcherBPC-157TB-500Thymosin Alpha-1
19 minLearn Peptides So Fast it's UNREALAshley Froese · EducatorGHK-CuKPVThymosin Alpha-1Frequently asked questions
What does the research show about GHK-Cu?
In laboratory studies, GHK-Cu shifts the activity of many genes, prompts collagen production, lowers some inflammatory signals and raises cells' own antioxidant enzymes. The human evidence is mostly for topical use on skin, plus small studies in wound settings. Evidence for hair growth and joints is laboratory or preclinical only.
Is GHK-Cu better than retinol for skin?
Nobody has tested them against each other, so any ranking is opinion. They work by different routes. Retinol has by far the larger body of clinical evidence behind it.
Does genetics affect how GHK-Cu works?
Nobody knows. Genes such as COL1A1, SOD2 and TGFB1 sit on pathways GHK-Cu acts on in laboratory studies, but no study has tested whether any genotype changes response to GHK-Cu.
How long did GHK-Cu skin studies run?
Skin turnover takes weeks and collagen remodelling longer, so skin studies run over months. No published trial pins down a precise timeline, and claims of results by a set week are user accounts rather than trial data.
What side effects have been reported with GHK-Cu?
Topical products are generally well tolerated in studies; redness, itching, stinging and dryness where applied are the usual complaints, and copper can leave a faint blue-green tint that washes off. Injectable GHK-Cu is not approved by the FDA for any use and has far less safety data. It has not been studied in pregnancy or breastfeeding, copper-handling disorders such as Wilson's disease make added copper a medical question, and its effect on blood vessel growth makes a cancer history a question for a doctor.
Is injectable GHK-Cu FDA-approved?
No. Injectable GHK-Cu is not approved by the FDA for any use.
This article is for informational and educational purposes only. It reports what published research found; it is not medical advice, it does not diagnose, treat, cure or prevent any disease, and nothing in it is a dose or a recommendation to use any compound. Talk to a licensed clinician about any medical decision.